INVO BioScience Inc. (INVO) Fundamentals

INVO Bioscience Inc operates as a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. The company has developed the INVOcell device and procedure, the first Intravaginal Culture (IVC) system granted FDA clearance in the United States used for the incubation of eggs and sperm during fertilization and early embryo development. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
SHARE INFORMATION
Market Cap$ 12,580,670
Shares Outstanding12,096,798
Float11,614,366
Percent Float96.01%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 4,160,116
Latest Fiscal EPS$ -0.63
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions37
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months15,118
Institutional Holdings Percent22.7%
Institutional Sold Previous 3 Months1,501
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months177,306
Insider Holdings Percent2.9
Insider Sold Previous 3 Months177,306
Insider Shares Owned356,235
TRADING INFO
52 Week High$ 4.28
52 Week Low$ 0.63
52 Week High Change$ -75.53
21 Day Moving Average$ 1.0344
21 Day Extended Moving Average$ 1.0266
50 Day Moving Average$ 0.9386
50 Day Extended Moving Average$ 1.0686
200 Day Moving Average$ 2.249
200 Day Extended Moving Average$ 2.0511
10 Day Average Volume24,964
20 Day Average Volume17,461
30 Day Average Volume17,972
50 Day Average Volume34,015
Alpha0.001081
Beta0.1936
Standard Deviation0.333587
R20.000843
7 Day Price Change$ -0.01
7 Day Percent Change-0.95%
21 Day Price Change$ 0.03
21 Day Percent Change2.97%
30 Day Price Change$ 0.08
30 Day Percent Change8.33%
Month to Date Price Change$ 0.05
Month to Date Percent Change5.05%
Quarter to Date Price Change$ 0.4001
Quarter to Date Percent Change62.53%
180 Day Price Change$ -2.01
180 Day Percent Change-65.9%
200 Day Price Change$ -1.77
200 Day Percent Change-62.99%
Year to Date Price Change$ -2.29
Year to Date Percent Change-68.77%

INVO BioScience Inc. (INVO) Key Ratios

PROFITABILITY
EBIT Margin-181.4%
EBITDA Margin-175.1%
Pre-Tax Profit Margin-363.8%
Profit Margin Count0.0%
Gross Margin96.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 3,429,719
Revenue Per Share$ 0.2835
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.50
Total Debt To Equity0.40
Int Coverage-17.80
Current Ratio4.10
Leverage Ratio1.50
Quick Ratio3.60
Long Term Debt To Capital0.25
VALUATION MEASURES
PE Ratio-1.90
Enterprise Value$ 11,898,664
Price to Sales3.6681
Price to Free Cash-1.80
PE High Last 5 Years-14.20
Price To Book2.50
Price To Cash Flow21.70
PE Low Last 5 Years-16.20
Price to Tangible Book2.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover10.40
Invoice Turnover0.50
Assets Turnover0.20
Return Assets-74.57
Return on Equity-124.69
Return on Capital-96.60

INVO BioScience Inc. (INVO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorM&K CPAS, PLLC
CEOSteven Shum
Emplyoees2
Last AuditUE
CIK0001417926
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address5582 Broadcast Court
Suite 34C
Sarasota, FL 34240
Websitehttps://www.invobioscience.com
Facsimile-
Telephone+1 978 878-9505
Emailinfo@invobioscience.com


Your Recent History
NASDAQ
INVO
INVO BioSc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.